Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, MARIMED INC. reported revenue of $160M, up 1.3% year over year. Operating margin was -1.8% and net margin -9.1%, on a free-cash-flow margin of 4.1% with capital expenditure at 0.7% of revenue. Every figure is computed directly from MRMD's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $160M | -1.8% | -9.1% |
| FY2024 | $158M | 1.7% | -7.9% |
| FY2023 | $149M | 9.7% | -10.8% |
| FY2022 | $134M | 15.2% | 10.0% |
| FY2021 | $121M | 22.1% | 5.9% |
How does MRMD compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
See MRMD benchmarked against two sector peers (free) →
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.